CSPC

Biomedical R&D company

CSPC, founded in June, 1992 and headquartered in Shijiazhuang, is a biopharmaceutical developer. The founder is Cai Dongchen. Listed on the HKEX on June 21, 1994, the company's major shareholders are Massive Top. Limited. Rivals that have direct and indirect competition with CSPC include 111 Group, JD health, Glaxo Smith Kline, Pfizer, etc.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Large Pharma

Founded

Jun 16, 1992

HQ location

Hebei, China

Legal name

Shijiazhuang Pharmaceutical Group Co., Ltd. (CSPC)

Employees

18039

See more